Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
New Zealand Brain Research Institute is an independent New Zealand brain research and clinical institute based in Christchurch focused on neurological and neurodegenerative disorders. The organization combines translational research, education, and specialist clinical services, with major programs in Parkinson’s disease and other movement disorders, dementia and Alzheimer’s disease, Huntington’s disease, multiple sclerosis, and neurotechnology. NZBRI runs longitudinal observational studies, epidemiology and imaging research, and disease-focused clinics rather than a traditional drug-development pipeline. It collaborates closely with the University of Otago, the University of Canterbury, health-system partners, and community organizations, and operates as a charitable subsidiary of the Canterbury Medical Research Foundation. For a biotech analyst, NZBRI is best understood as an active nonprofit neuroscience research institute and clinical research center rather than a commercial therapeutics company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on New Zealand Brain Research Institute.